[
  {
    "ts": null,
    "headline": "MRK Purchasers Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit",
    "summary": "NEW YORK, March 28, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Merck & Co., Inc. ...",
    "url": "https://finnhub.io/api/news?id=cb2918981561b7efc7ed383484d294842b35e1141cf6b4bf23f30c030988cfea",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743183605,
      "headline": "MRK Purchasers Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit",
      "id": 133525061,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "NEW YORK, March 28, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Merck & Co., Inc. ...",
      "url": "https://finnhub.io/api/news?id=cb2918981561b7efc7ed383484d294842b35e1141cf6b4bf23f30c030988cfea"
    }
  },
  {
    "ts": null,
    "headline": "Merck & Co. Inc. stock outperforms competitors on strong trading day",
    "summary": "Merck & Co. Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=78fcfae1e9fe0e26716b9757368bce8c74fb108af2fbfe549a9a895abd7b16b5",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743179580,
      "headline": "Merck & Co. Inc. stock outperforms competitors on strong trading day",
      "id": 133545820,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Merck & Co. Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=78fcfae1e9fe0e26716b9757368bce8c74fb108af2fbfe549a9a895abd7b16b5"
    }
  },
  {
    "ts": null,
    "headline": "FDA Accepts Merck's Filing for Subcutaneous Version of Keytruda",
    "summary": "The filing is based on late-stage data, which shows that treatment with the subcutaneous version of MRK's Keytruda is at least as effective as the IV version.",
    "url": "https://finnhub.io/api/news?id=a86ef02f5d85de372473b933fc447db79b4d8e9578fdb2b03e32f392add0ee83",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743175200,
      "headline": "FDA Accepts Merck's Filing for Subcutaneous Version of Keytruda",
      "id": 133523803,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "The filing is based on late-stage data, which shows that treatment with the subcutaneous version of MRK's Keytruda is at least as effective as the IV version.",
      "url": "https://finnhub.io/api/news?id=a86ef02f5d85de372473b933fc447db79b4d8e9578fdb2b03e32f392add0ee83"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Vs. Sanofi: Which Is The Better Investment Right Now",
    "summary": "AbbVie Vs. Sanofi: Which Is The Better Investment Right Now",
    "url": "https://finnhub.io/api/news?id=2ec9b46a156413c058393a72e5bee50e867a91233b35571d7b5b27f08d74bd75",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743155082,
      "headline": "AbbVie Vs. Sanofi: Which Is The Better Investment Right Now",
      "id": 133508460,
      "image": "",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=2ec9b46a156413c058393a72e5bee50e867a91233b35571d7b5b27f08d74bd75"
    }
  },
  {
    "ts": null,
    "headline": "Merck's Investigational Subcutaneous Pembrolizumab with Berahyaluronidase Alfa Demonstrates Noninferior Pharmacokinetics Compared to Intravenous KEYTRUDA in Pivotal 3475A-D77 Trial",
    "summary": "RAHWAY - Merck , known as MSD outside of the United States and Canada, today announced the first data presentation from the pivotal 3475A-D77 Phase 3 trial, evaluating the subcutaneous administration...",
    "url": "https://finnhub.io/api/news?id=4a3af87dabfe3f9ee7c2f0638fe33398402c981fe888ab6c325a497aa3c88a3e",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743154808,
      "headline": "Merck's Investigational Subcutaneous Pembrolizumab with Berahyaluronidase Alfa Demonstrates Noninferior Pharmacokinetics Compared to Intravenous KEYTRUDA in Pivotal 3475A-D77 Trial",
      "id": 133508390,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "RAHWAY - Merck , known as MSD outside of the United States and Canada, today announced the first data presentation from the pivotal 3475A-D77 Phase 3 trial, evaluating the subcutaneous administration...",
      "url": "https://finnhub.io/api/news?id=4a3af87dabfe3f9ee7c2f0638fe33398402c981fe888ab6c325a497aa3c88a3e"
    }
  },
  {
    "ts": null,
    "headline": "Lost Money on Merck & Co., Inc.(MRK)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky",
    "summary": "NEW YORK, March 28, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Merck & Co., Inc. of a class action securities lawsuit. ...",
    "url": "https://finnhub.io/api/news?id=5d04041ef3a7dbf9c9c763ed8ca5e1058e3977b9614035e96bd8e6509f79815e",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743140782,
      "headline": "Lost Money on Merck & Co., Inc.(MRK)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky",
      "id": 133506575,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "NEW YORK, March 28, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Merck & Co., Inc. of a class action securities lawsuit. ...",
      "url": "https://finnhub.io/api/news?id=5d04041ef3a7dbf9c9c763ed8ca5e1058e3977b9614035e96bd8e6509f79815e"
    }
  },
  {
    "ts": null,
    "headline": "Germany's Merck Teams Up With Abbisko for Global Sale Rights of Bone-Tumor Drug",
    "summary": "Germany's Merck Teams Up With Abbisko for Global Sale Rights of Bone-Tumor Drug",
    "url": "https://finnhub.io/api/news?id=dc86a4369a41a090da232b8f4f6b694660cf836f41718fdec0b23116a08a1883",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743129120,
      "headline": "Germany's Merck Teams Up With Abbisko for Global Sale Rights of Bone-Tumor Drug",
      "id": 133510180,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Germany's Merck Teams Up With Abbisko for Global Sale Rights of Bone-Tumor Drug",
      "url": "https://finnhub.io/api/news?id=dc86a4369a41a090da232b8f4f6b694660cf836f41718fdec0b23116a08a1883"
    }
  }
]